Makers Laboratories Ltd-$
Makers Laboratories Ltd-$ (MAKERSL) last reported results for the quarter ended Jun 2026, with sales of ₹42.77 crore and net profit of ₹4.59 crore. The next scheduled event is an EGM on 16 Oct 2026. The stock last traded at ₹177, a market capitalisation of ₹103 crore, on a P/E of 30.2. Over the past 52 weeks the stock has ranged between ₹109 and ₹237. Figures are as of 9 Oct 2026 and are not real time.
Makers Laboratories Ltd-$ share price and key metrics
- Current price
- ₹177
- Market cap
- ₹103 cr
- Stock P/E
- 30.2
- Book value
- ₹124
- ROE
- 3.17%
- ROCE
- 9.28%
- Dividend yield
- 0.00%
- 52w high / low
- 237/109
Metrics as of 9 Oct 2026. Not real time.
Track Makers Laboratories Ltd-$
Cruxal reads every Makers Laboratories Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Makers Laboratories Ltd-$ growth and returns
- 10 Years
- %
- 5 Years
- 15%
- 3 Years
- 12%
- TTM
- 18%
- 10 Years
- %
- 5 Years
- 49%
- 3 Years
- 35%
- TTM
- -61%
- 10 Years
- 10%
- 5 Years
- -3%
- 3 Years
- 18%
- 1 Year
- 34%
- 10 Years
- %
- 5 Years
- -1%
- 3 Years
- -2%
- Last Year
- 3%
Makers Laboratories Ltd-$ quarterly results
In the quarter ended Jun 2026, sales were ₹42.77 cr, up 22.2% from ₹35 cr a year earlier. Net profit was ₹4.59 cr, up 255.8% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 29.57 | 27.69 | 33.9 | 35 | 34.17 | 35.67 | 35.75 | 42.77 |
| Expenses | 27.38 | 26.38 | 30.81 | 31.99 | 31.89 | 31.51 | 30.47 | 35.81 |
| Operating profit | 2.19 | 1.31 | 3.09 | 3.01 | 2.28 | 4.16 | 5.28 | 6.96 |
| OPM % | 7.41% | 4.73% | 9.12% | 8.60% | 6.67% | 11.66% | 14.77% | 16.27% |
| Other income | 10.63 | 0.87 | 0.1 | 0.27 | 0.36 | 0.33 | 0.76 | 0.61 |
| Interest | 0.43 | 0.19 | 0.18 | 0.18 | 0.22 | 0.2 | 0.17 | 0.15 |
| Depreciation | 1.29 | 1.31 | 0.9 | 1.12 | 1.13 | 1.14 | 1.13 | 1.13 |
| Profit before tax | 11.1 | 0.68 | 2.11 | 1.98 | 1.29 | 3.15 | 4.74 | 6.29 |
| Tax % | 11.98% | 60.29% | 24.64% | 34.85% | 42.64% | 27.94% | 24.89% | 27.03% |
| Net profit | 9.76 | 0.27 | 1.58 | 1.29 | 0.74 | 2.27 | 3.56 | 4.59 |
| EPS (₹) | 14.95 | -0.51 | -0.08 | 0.75 | -0.20 | 1.59 | 1.85 | 2.54 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Makers Laboratories Ltd-$ annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 69 | 127 | 101 | 104 | 121 | 141 | 148 |
| Operating profit | 8 | 19 | 3 | 1 | 9 | 15 | 19 |
| OPM % | 12% | 15% | 3.3% | 1.1% | 7% | 11% | 13% |
| Net profit | 1 | 12 | -2 | -5 | 11 | 8 | 11 |
| EPS (₹) | -0.56 | 8.44 | -8.05 | -10.61 | 12.69 | 3.98 | 5.78 |
TTM is the trailing twelve months to the most recent quarter.
Makers Laboratories Ltd-$ balance sheet
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 5 | 5 | 6 | 6 | 6 | 6 |
| Reserves | 49 | 55 | 63 | 57 | 65 | 67 |
| Borrowings | 21 | 23 | 17 | 22 | 8 | 9 |
| Other liabilities | 62 | 62 | 66 | 76 | 70 | 85 |
| Total liabilities | 136 | 144 | 152 | 161 | 148 | 167 |
| Fixed assets | 71 | 68 | 85 | 87 | 74 | 71 |
| CWIP | 0 | 9 | 0 | 0 | 1 | 4 |
| Investments | 2 | 0 | 0 | 3 | 0 | 12 |
| Other assets | 63 | 66 | 67 | 71 | 73 | 81 |
| Total assets | 136 | 144 | 152 | 161 | 148 | 167 |
As reported by the company. Total assets equal total liabilities by construction.
Makers Laboratories Ltd-$ cash flow
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 0 | 18 | -9 | 1 | -4 | 14 |
| Cash from investing | 0 | -22 | 1 | -7 | 20 | -15 |
| Cash from financing | 0 | 0 | 6 | 6 | -16 | 0 |
| Net cash flow | 0 | -3 | -2 | -0 | -0 | -0 |
| Free cash flow | 0 | 9 | -21 | -6 | 11 | 11 |
| CFO / operating profit | 0% | 128% | -185% | 232% | -20% | 118% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Makers Laboratories Ltd-$ operating ratios
| Per year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | — | 15% | 1% | -2% | 4% | 9% |
| Debtor days | 88 | 39 | 72 | 70 | 85 | 52 |
| Inventory days | 344 | 166 | 281 | 227 | 230 | 250 |
| Days payable | 182 | 38 | 91 | 112 | 79 | 110 |
| Cash conversion cycle | 250 | 167 | 262 | 185 | 236 | 192 |
| Working capital days | 112 | 61 | 113 | 97 | 140 | 106 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Makers Laboratories Ltd-$ shareholding pattern
Promoters held 61.28% at Jun 2026, broadly unchanged since Jun 2025. DIIs 0.39%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% | 61.28% |
| DIIs | 0.00% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% |
| Public | 38.73% | 38.33% | 38.34% | 38.35% | 38.35% | 38.35% | 38.34% | 38.34% |
| No. of shareholders | 4,008 | 4,031 | 4,135 | 4,073 | 4,026 | 3,926 | 3,801 | 3,745 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Makers Laboratories Ltd-$ events
The next scheduled event is an EGM on 16 Oct 2026.
- EGMApproval for appointment/continuation of Mr. Saahil Parikh as a Non-Executive, Non-Independent Director
See the full results calendar for every Indian company reporting in the next 30 days.
Makers Laboratories Ltd-$ corporate filings
- Closure of Trading WindowInsider Trading / SASTlow impact
- Makers Laboratories Ltd publishes mandatory newspaper notice for regulatory complianceCompany Updatelow impact
Cruxal's analysis: Makers Laboratories Ltd has fulfilled a routine regulatory requirement under Regulation…
Read the full analysis - Makers Laboratories Ltd. seeks shareholder approval for transition of Mr. Saahil Parikh from Whole-time Director to Non-Executive, Non-Independent DirectorAGM/EGMlow impact
Cruxal's analysis: Makers Laboratories Ltd. has issued a Postal Ballot notice to seek shareholder approval…
Read the full analysis - Makers Laboratories Limited: CARE Edge Ratings Reaffirms Long-Term Bank Facility Rating at CARE BBB+; StableCompany Updatelow impact
Cruxal's analysis: Makers Laboratories Limited has received a reaffirmation of its long-term bank facilities…
Read the full analysis - Makers Laboratories Ltd publishes newspaper notice regarding financial resultsCompany Updatelow impact
Cruxal's analysis: Makers Laboratories Ltd has fulfilled its regulatory obligation under Regulation 30 of…
Read the full analysis - Makers Laboratories Limited concludes 41st Annual General Meeting with approval of all resolutionsAGM/EGMlow impact
Cruxal's analysis: Makers Laboratories Limited has successfully concluded its 41st Annual General Meeting…
Read the full analysis - Makers Laboratories Ltd. Concludes 41st Annual General Meeting; Approves Financial Statements and Related Party TransactionsAGM/EGMlow impact
Cruxal's analysis: Makers Laboratories Ltd. has successfully concluded its 41st Annual General Meeting held…
Read the full analysis - Makers Laboratories Reports Q1 FY27 Financial Results and Announces CEO TransitionBoard Meetinghigh impact
Cruxal's analysis: Makers Laboratories Limited reported a standalone net loss of 1.05 crore for the quarter…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.